Lifestyle and Economy Archives

January 2021

1/28/2021

  • More than 48.3 million doses of COVID-19 vaccines have been distributed across the U.S., and more than 21.7 million people have received their first dose, according to CDC data.
  • A COVID-19 vaccine from Novavax proved nearly 90 percent effective in preliminary results from a key clinical trial in the U.K., but in a separate trial appeared far less effective against the new variant from South Africa.
  • Preliminary findings from an NIH study suggest pregnant women who experienced severe symptoms of COVID-19 had a higher risk of complications during and after pregnancy. Compared to COVID-19 patients without symptoms, the NIH study showed that those with severe symptoms were at higher risk for cesarean delivery, postpartum hemorrhage, hypertensive disorders of pregnancy and preterm birth. The researchers also found transmission of COVID-19, from mother to child was rare, with 1 percent of newborns testing positive for the virus before being discharged from the hospital.
  • CDC's MMWR published a few new articles of interest:
  • New York has not mentioned prison inmates in its vaccine eligibility guidelines. At least 5,100 people living and working in New York’s prisons have tested positive for COVID-19 and 12 have died in recent weeks, outpacing the early days of the pandemic.
  • COVID-19 cost global tourism $1.3 trillion in 2020 according to the U.N.
  • The IMF has raised its forecast for global economic growth in 2021 and said the coronavirus-triggered downturn in 2020 would be nearly a full percentage point less severe than expected.
  • Overlake Medical Center & Clinics in Bellevue, Washington, is receiving backlash after sending an email to about 110 donors who gave more than $10,000 to the hospital system, telling them they could register for open appointments “by invite” only.
  • The Arkansas Department of Health has confirmed that a central Arkansas house cat was found to be infected with COVID-19.
  • German authorities have blocked the use of the AstraZeneca vaccine on people over age 65. A statement by the Standing Vaccine Commission at the Robert Koch Institute (RKI), Germany’s main public health agency said there is “insufficient data currently available to ascertain how effective the vaccination is above 65 years.”
  • A second company has provided preliminary evidence that proactively infusing healthy people with monoclonal antibodies against SARS-CoV-2 prevents them from developing noticeable symptoms of COVID-19 if they are exposed to the coronavirus. In a press release earlier this week, Regeneron revealed that when it gave a cocktail of two of those antibodies to 186 people living in a house with someone who had COVID-19, none developed symptomatic disease.
  • Eli Lilly is testing its COVID-19 antibody therapy in combination with another treatment by Vir Biotechnology Inc and its partner GlaxoSmithKline, to combat new variants of the coronavirus.
  • The French Cannes 2021 film festival will take place between July 6-17 instead of May 11-22 as initially planned.
  • The International Swimming Federation, known as FINA, postponed its artistic-swimming qualification event for the Tokyo Olympics because of COVID-19. The competition was supposed to be held at the Tokyo Aquatics Center in March but has been rescheduled for May.
  • The WHO keeps a running list of COVID-19 vaccine candidates, which you can view here. STAT News also has a resource tracking COVID-19 drugs and vaccines. The New York Times has a very helpful vaccine tracker as well, which you can view here. This AVAC pipeline tracker is great, too.
  • The Johns Hopkins Center for Health Security has an extensive list of commercial and lab-developed tests.
  • Continue to look at the NIH Office of Portfolio Analysis’s (OPA) expert-curated portfolio of COVID-19 publications and preprints. The portfolio includes peer-reviewed articles from PubMed and preprints from medRxiv, bioRxiv, ChemRxiv, and arXiv. It is updated daily with the latest available data and enables users to explore and analyze the rapidly growing set of advances in COVID-19 research.

1/25/2021

  • More than 41.4 million doses of COVID-19 vaccines have been distributed across the U.S., and more than 18.5 million people have received their first dose, according to CDC data.
  • Moderna announced Monday that their COVID-19 vaccine protects against two variants of the virus detected in Britain and South Africa. However, test results indicated the vaccine is less effective at neutralizing the South African variant. As a result, Moderna will launch two new studies – including adding a third vaccine dose to boost effectiveness.
    • The variant identified in Britain has been confirmed in 22 states, and the variant found in South Africa has not yet been confirmed in the U.S.
  • Pharmaceutical company Merck & Co. announced today that it will shut down its COVID-19 vaccine program. Early studies showed inferior immune responses when compared to other vaccines.
  • Pfizer announced that it has fully enrolled its COVID-19 vaccine trial in kids ages 12-15.
  • Johnson and Johnson said it expects to release data later this month from the Phase 3 trial of its single-dose coronavirus vaccine, which was shown to generate an immune response to COVID-19 in an early-stage study.
  • An MMWR report about the NFL shared that the League observed SARS-CoV-2 transmission after <15 minutes of cumulative interaction, leading to a revised definition of a high-risk contact that evaluated mask use and ventilation in addition to duration and proximity of interaction. Overall, intensive mitigation protocols effectively reduced close interactions. The authors added that post-exposure quarantine based on redefined high-risk criteria, combined with testing and environment-specific intensive protocols, can protect communities before and after case identification.
  • A case of a more contagious coronavirus variant first found in Brazil has been confirmed in Minnesota and is the first confirmed case of the variant in the U.S. The variant, known as B.1.1.28.1 or P.1, shares many mutations with one first identified in South Africa.
  • The NIH shared the results from a large clinical trial that saw full dose anti-coagulation (blood thinner) treatments given to moderately ill patients hospitalized for COVID-19 reduced the requirement of vital organ support—such as the need for ventilation.
  • Early results in Israel show a significant drop in infection after just one shot of a two-dose COVID-19 vaccine, and better than expected results after both doses.
  • The International Labour Organization (ILO) estimated COVID-19 has caused $3.7 trillion in lost earnings to workers. The ILO said women, younger workers, and people in hospitality and retail were hit the hardest. They also stated that 8.8 percent of working hours were lost relative to 2019, which is four times bigger than the impact of the 2008 financial crisis.
  • Google said it will make company buildings, parking lots, and open spaces available to serve as temporary vaccination clinics in partnership with health care providers and public health officials.
  • Oxfam released a report stating that COVID-19 has created a wealth increase of $550 million for the ten richest men.
  • Because so many schools nixed the standardized test requirement for applications, the volume of college applications submitted by January deadlines was 10 percent higher than last year, amounting to almost 5.6 million applications through Jan. 18. According to the Common App, the increase was driven largely by an increase in applications to the most selective universities, which rose 17 percent, and to the largest universities, which rose 16 percent.
  • The WHO is providing risk management advice to the International Olympic Committee (IOC) and Japanese authorities about the Tokyo Olympics.
  • Budweiser, an Anheuser-Busch company, is foregoing Super Bowl commercials and is instead donating portions of its advertising budget this year to the Ad Council, a nonprofit marketing group at the helm of a $50 million ad blitz to fight vaccine hesitancy.
  • The University of Michigan said Saturday that it had suspended all sports activities for up to two weeks and told athletes, coaches, and team staff members to quarantine immediately after “several” cases of the U.K. variant of the coronavirus were found among people linked to the athletic department.
  • The WHO keeps a running list of COVID-19 vaccine candidates, which you can view here. STAT News also has a resource tracking COVID-19 drugs and vaccines. The New York Times has a very helpful vaccine tracker as well, which you can view here. This AVAC pipeline tracker is great, too.
  • The Johns Hopkins Center for Health Security has an extensive list of commercial and lab-developed tests.
  • Continue to look at the NIH Office of Portfolio Analysis’s (OPA) expert-curated portfolio of COVID-19 publications and preprints. The portfolio includes peer-reviewed articles from PubMed and preprints from medRxiv, bioRxiv, ChemRxiv, and arXiv. It is updated daily with the latest available data and enables users to explore and analyze the rapidly growing set of advances in COVID-19 research.

1/21/2021

  • More than 37.9 million doses of COVID-19 vaccines have been distributed across the U.S., and more than 15 million people have received their first dose, according to CDC data.
  • The Independent Panel for Pandemic Preparedness and Response prepared and published their second report on progress for the WHO Executive Board.
  • A recent MMWR article looked at vaccination coverage among kindergarteners in the U.S. in the 2019-2020 school year. National coverage for that year was about 95 percent for diphtheria and tetanus toxoids, and acellular pertussis; measles, mumps, and rubella; and varicella vaccines. However, the article notes the disruption in vaccinations during the COVID-19 pandemic. Ultimately, the authors recommend increased follow-up of undervaccinated students.
  • Another MMWR study examined contact tracing efforts from health departments for a month between June and July of 2020. The findings showed that, of case investigation and contact tracing metric data reported by 56 U.S. health departments, there was wide variation in capacity and ability to conduct timely and effective contact tracing. The authors suggest that increasing staffing capacity and improving community engagement could lead to more timely contact tracing interviews and identification of more contacts.
  • Eli Lilly released new data showing that a laboratory-made protein delivered by infusion may help prevent infections at nursing homes. A Phase 3 clinical trial found that nursing home residents who got the monoclonal antibody drug were 80 percent less likely to develop symptomatic COVID-19 compared to nursing home residents who got a placebo infusion.
  • The Pfizer COVID-19 vaccine appears to work just as well against a fast-spreading variant of the coronavirus first identified in the U.K. as it does against earlier forms of the pathogen, the companies reported in a study Wednesday.
  • United Airlines said it expected to have voluntary COVID-19 testing available at all of its hubs by February.
  • Rio de Janeiro Mayor Eduardo Paes said the 2021 Rio Carnival will be postponed due to Brazil’s second wave of coronavirus and a lagging vaccination campaign.
  • The UK’s largest music festival “Glastonbury” has been canceled for a second time.
  • While the French ski slopes have remained closed, resorts in Switzerland have decided to open. Although the French Government have urged people to stay away, many ignored the recommendations. The large crowds make social distancing difficult have heightened public health concerns, as highly contagious variants of the virus spread across Europe.
  • The WHO keeps a running list of COVID-19 vaccine candidates, which you can view here. STAT News also has a resource tracking COVID-19 drugs and vaccines. The New York Times has a very helpful vaccine tracker as well, which you can view here. This AVAC pipeline tracker is great, too.
  • The Johns Hopkins Center for Health Security has an extensive list of commercial and lab-developed tests.
  • Continue to look at the NIH Office of Portfolio Analysis’s (OPA) expert-curated portfolio of COVID-19 publications and preprints. The portfolio includes peer-reviewed articles from PubMed and preprints from medRxiv, bioRxiv, ChemRxiv, and arXiv. It is updated daily with the latest available data and enables users to explore and analyze the rapidly growing set of advances in COVID-19 research.

1/19/2021

  • More than 31 million doses of COVID-19 vaccines have been distributed across the U.S., and nearly 11 million people have received their first dose, according to CDC data updated as of Jan. 15.
  • COVID-19 vaccine coverage is twice as high among white people than it is among Black and Hispanic people according to one recent analysis. At least 14 states publish vaccine administration data by race on local dashboards or reports, and at least 13 states report it by ethnicity.
  • New York State is having a difficult time vaccinating nursing home workers who are opting out. As of Monday, only about 37 percent of the more than 130,000 people working in “skilled nursing” facilities in the state have been vaccinated, according to the governor’s office.
  • A new commentary co-authored by NIH's Dr. Tony Fauci and other leading NIAID scientists in the journal Annals of Internal Medicine provides an overview of the seven COVID-19 vaccines furthest along in development in the U.S. For each vaccine candidate, the authors describe the platform used, the current stage of development, and the clinical trial results that have been reported or when results are expected.
  • The American Academy of Pediatrics and the Children’s Hospital Association found over 211,000 new COVID-19 cases among kids last week – the highest number since the pandemic began, according to a newly released report.
  • Widespread use of face masks in a community can significantly help prevent large outbreaks of COVID-19, according to a study published Tuesday in The Lancet Digital Health. A 10 percent increase in self-reported mask-wearing could lead to a three-fold increase in the odds of maintaining sufficient control over virus transmission in a community, the study said.
  • Pfizer said shipments to Canada and the E.U. from its vaccine facility in Puurs, Belgium, will be temporarily reduced as it scales up to produce two billion COVID-19 vaccine doses in 2021. The company said there will be fluctuations in orders and shipping schedules from the facility in late January and early February.
  • Seventy-two tennis players who arrived ahead of the Australian Open, set to begin Feb. 8, have been confined to their hotel rooms and prohibited from practicing as part of strict quarantine rules implemented after passengers on their flights to the grand slam tournament tested positive for COVID-19. Two players and one non-player associated with the tournament tested positive for COVID-19 on Monday.
  • Emirates Airlines and Etihad Airways said they have partnered with the International Air Transport Association to trial IATA Travel Pass ­– a mobile app that serves as a “digital passport” to verify pre-travel COVID-19 testing or vaccination status. Emirates Airlines said it plans to roll out the first phase to passengers departing Dubai in April, and Etihad will first offer the travel pass on some flights out of Abu Dhabi in the first quarter of 2021.
  • A Scottish woman who lived through two world wars and the 1918 flu pandemic has received her first dose of coronavirus vaccine on her 108th birthday.
  • The 2021 New Orleans Jazz Fest has been postponed until October.
  • Boston’s St. Patrick’s Day parade has been canceled for the second year in a row.
  • The WHO keeps a running list of COVID-19 vaccine candidates, which you can view here. STAT News also has a resource tracking COVID-19 drugs and vaccines. The New York Times has a very helpful vaccine tracker as well, which you can view here. This AVAC pipeline tracker is great, too.
  • The Johns Hopkins Center for Health Security has an extensive list of commercial and lab-developed tests.
  • Continue to look at the NIH Office of Portfolio Analysis’s (OPA) expert-curated portfolio of COVID-19 publications and preprints. The portfolio includes peer-reviewed articles from PubMed and preprints from medRxiv, bioRxiv, ChemRxiv, and arXiv. It is updated daily with the latest available data and enables users to explore and analyze the rapidly growing set of advances in COVID-19 research.

1/14/2021

  • More than 30.6 million doses of COVID-19 vaccines have been distributed across the U.S., and more than 11 million people have received their first dose, according to CDC data.
  • Early-stage trials of Johnson & Johnson's experimental coronavirus vaccine show it generated an immune response in nearly all volunteers, with minimal side-effects, after a single dose.
  • People who received two shots of the Moderna COVID-19 vaccine in its earliest, Phase 1 clinical trial are being offered a third shot, a so-called booster, as part of a continuing study to determine whether repeated vaccinations are needed, and whether they are safe and effective.
  • People who have recovered from COVID-19 may have immunity to the virus for around five months, according to preliminary findings in a new study led by Public Health England.
  • In an HHS-funded study, patients hospitalized with COVID-19 who were not receiving mechanical ventilation had a lower risk of death if they received a transfusion of plasma with higher coronavirus antibody levels than a transfusion of plasma with lower antibody levels.
  • Based on global surveillance data collected through late last month, the WHO says flu activity in the Northern Hemisphere is at “interseasonal levels,” meaning it’s as low as in an ordinary summer. In the U.S., the percentage of outpatient visits for influenza-like illness is at 1.6 percent, far below the 2.6 percent baseline used to define a seasonal epidemic. U.S. clinical labs have collected 925 positive samples since the end of September 2020, versus 63,975 at this point in the 2019–20 flu season.
  • Scientists at Ohio State University’s Wexner Medical Center and College of Medicine have discovered a new variant of the coronavirus that is similar to the mutation found in the U.K. but probably originated in the U.S., researchers announced Wednesday.
  • After declining over the summer, coronavirus infections among children, teens, and young adults rose steadily from September through mid-December, paralleling the virus’s trajectory among older adults in the U.S. population, the CDC reported on Wednesday.
  • Another study of children, adolescents, and young adults, published in JAMA Pediatrics on Monday by researchers at the University of Minnesota, found that the increase in the percentage of children hospitalized with COVID-19 was more than double that of adults over the same period. Child hospitalizations surged by 760 percent, while adult hospitalizations increased by 300 percent.
  • A coalition of leading technology companies, health organizations, and nonprofits — including Microsoft, Oracle, Salesforce, Cerner, Epic Systems, and the Mayo Clinic — said on Thursday that they were developing technology standards to enable people to obtain and share their immunization records through health passport apps.
  • New claims for state unemployment benefits in the U.S. sharply increased last week. A total of 1.15 million workers filed initial claims for state unemployment benefits during the first full week of the new year.
  • Unlike the jobless rate, which has declined markedly from the peak in April, the rate of absenteeism has remained stubbornly high. More than 1.9 million people missed work in December because of illness, according to Labor Department data, almost matching the 2 million record set in April and underscoring the impact of a third wave of coronavirus infections. This is beginning to greatly affect U.S. supply chains.
  • The Vatican said on Thursday that Pope Francis and Pope Emeritus Benedict XVI had each received the first dose of a coronavirus vaccine.
  • Tennis player Andy Murray has tested positive for COVID-19, putting in doubt his participation in next month’s Australian Open.
  • The Girl Scouts of the U.S.A. said on Tuesday that they would offer contactless delivery and pickup of their cookies through Grubhub. It’s the first time that the Girl Scouts, who have sold cookies for more than a century, have collaborated with a national delivery service.
  • The English Premier League announced on Thursday that Aston Villa’s home game against Everton has been postponed due to the ongoing COVID-19 outbreak at the Midlands club. A total of six Premier League matches have been postponed due to the pandemic so far.
  • Flights were delayed when an air traffic control center near Jacksonville, Florida, closed for several hours for extensive cleaning after an employee tested positive for the coronavirus.
  • The WHO keeps a running list of COVID-19 vaccine candidates, which you can view here. STAT News also has a resource tracking COVID-19 drugs and vaccines. The New York Times has a very helpful vaccine tracker as well, which you can view here. This AVAC pipeline tracker is great, too.
  • The Johns Hopkins Center for Health Security has an extensive list of commercial and lab-developed tests.
  • Continue to look at the NIH Office of Portfolio Analysis’s (OPA) expert-curated portfolio of COVID-19 publications and preprints. The portfolio includes peer-reviewed articles from PubMed and preprints from medRxiv, bioRxiv, ChemRxiv, and arXiv. It is updated daily with the latest available data and enables users to explore and analyze the rapidly growing set of advances in COVID-19 research.

1/11/2021

  • More than 25.4 million doses of COVID-19 vaccines have been distributed across the U.S., and nearly 9 million people have received their first dose, according to CDC data.
  • States are increasingly abandoning guidelines from the CDC and taking their own approaches to giving people coronavirus vaccines, new analysis finds.
  • Reports on new SARS-CoV-2 variants are available here.
  • Two independent analyses have found that a new SARS-CoV-2 variant overtaking the U.K. is indeed more transmissible than other forms of the virus. Both found it to be roughly 50 percent more transmissible than other variants.
  • Under a range of assumptions of presymptomatic transmission and transmission from individuals with infection who never develop symptoms, the model presented in this study estimated that more than half of transmission comes from asymptomatic individuals.
  • In a study investigating the long-term health effects of COVID-19, 76 percent (1265 of 1655) of the patients reported at least one symptom that persisted 6-months after being diagnosed, with fatigue or muscle weakness being the most frequently reported symptom (63 percent, 1038 of 1655). More than half of patients presented with residual chest imaging abnormalities.
  • A recent MMWR article found rates of COVID-19 among nursing home residents and staff members increased during June and July 2020, and again in November. Trends in reported COVID-19 cases among nursing home residents and staff members were similar to trends in incidence of COVID-19 in surrounding communities.
  • Pope Francis says he will soon receive a COVID-19 vaccination, perhaps as early as next week, and said receiving the vaccine is a duty for everyone.
  • Nurses in the Chicago Public Schools district have objected to officials’ plans to begin bringing students back to classrooms on Monday, saying they do not think it is safe to do so.
  • COVID-19 killed more law enforcement officers in the line of duty than anything else in 2020, according to a new report.
  • The NBA has postponed two games due to COVID-19 safety protocols: New Orleans Pelicans vs. Dallas Mavericks originally scheduled for Monday night and Tuesday’s matchup between the Boston Celtics and host Chicago Bulls.
  • Support for holding the Olympics in Japan this summer has plummeted, according to a new poll from Kyodo News Agency that found that roughly 80 percent of respondents felt the event should be canceled or rescheduled.
  • Two captive gorillas at the San Diego Zoo have tested positive for COVID-19 after falling ill, and a third gorilla appears also to be symptomatic.
  • The International Energy Agency (IEA) has said global carbon emissions, which have been reduced by the pandemic, are set to rebound in 2021 unless governments take swift policy action.
  • After an 18-hour flight from Dubai landed in Auckland, New Zealand, in September, local health authorities discovered evidence of an outbreak that most likely occurred during the trip. Using seat maps and genetic analysis, the new study determined that one passenger initiated a chain of infection that spread to four others en route.
  • An international trial of the use of convalescent blood plasma on COVID-19 patients with moderate and severe illness has halted enrolment of severely ill patients requiring intensive care after it found no benefit.
  • Delays were reported at Ronald Reagan Washington National Airport after an air traffic control center that serves the area reported a coronavirus infection and closed for cleaning on Sunday.
  • The University of California is planning to return to primarily in-person instruction statewide beginning fall 2021 as access to COVID-19 vaccines becomes more widely accessible.
  • Dodger Stadium will become a COVID-19 vaccination site by the end of the week and will no longer offer testing after today. Once the site is fully operational, up to 12,000 people can be vaccinated per day.
  • The WHO keeps a running list of COVID-19 vaccine candidates, which you can view here. STAT News also has a resource tracking COVID-19 drugs and vaccines. The New York Times has a very helpful vaccine tracker as well, which you can view here. This AVAC pipeline tracker is great, too.
  • The Johns Hopkins Center for Health Security has an extensive list of commercial and lab-developed tests.
  • Continue to look at the NIH Office of Portfolio Analysis’s (OPA) expert-curated portfolio of COVID-19 publications and preprints. The portfolio includes peer-reviewed articles from PubMed and preprints from medRxiv, bioRxiv, ChemRxiv, and arXiv. It is updated daily with the latest available data and enables users to explore and analyze the rapidly growing set of advances in COVID-19 research.

1/7/2021

  • More than 21 million doses of COVID-19 vaccines have been distributed across the U.S., and 5.9 million people have received their first dose, according to CDC data.
  • Nearly 60 percent of all COVID-19 spread may come from people with no symptoms, according to a new MMWR report from the CDC.
  • The spread of the coronavirus accelerated sharply in counties where large universities held classes in person last fall, according to another MMWR study by the CDC.
  • The CDC released an MMWR report with data estimates that life-threatening allergic reactions could occur in about 11 out of every 1 million COVID-19 vaccine shots given. The CDC’s estimate is based on 21 cases of anaphylaxis following a 10-day period after the administration of 1.9 million doses of the Pfizer vaccine. The vast majority of these reactions – 71 percent –occurred within 15 minutes of the vaccination.
  • As of January 4, national forecasts predict that 12,900 to 24,900 new COVID-19 deaths will be reported during the week ending Jan. 30. These forecasts predict 405,000 to 438,000 total COVID-19 deaths in the U.S. by Jan. 30. In an interview with NPR, Dr. Fauci said the continued high toll would probably be a reflection of increased travel and gatherings over the holidays.
  • Blood plasma from recovered COVID-19 patients can help older adults avoid getting seriously sick with the coronavirus if the therapy is administered within days of the onset of the illness, a clinical trial in Argentina found.
  • New data suggest that nearly all COVID-19 survivors have the immune cells necessary to fight re-infection. The findings, published in the Jan. 6, 2021, online edition of Science, could mean that COVID-19 survivors have protective immunity against serious disease from the SARS-CoV-2 virus for months, perhaps years after infection.
  • The Grammy Awards, originally scheduled to take place on Jan. 31, have been postponed to March 14 due to the crisis-level COVID-19 situation in Los Angeles.
  • Saudi Arabia is urging Muslims to receive a coronavirus vaccine before performing Hajj or Umrah, religious pilgrimages to the country’s holy city of Mecca.
  • A pilot program will provide vaccines to some people imprisoned in federal prisons in Ottawa, Canada starting Friday. Six hundred inmates will each get two doses of vaccine in the first round, with prioritization of the sick and elderly.
  • So many dogs have been adopted during the pandemic that animal shelters in the DMV area are running out of pets.
  • Most nursing-home employees in North Carolina are refusing coronavirus vaccines, the state’s top public health official said Tuesday. And a third of health workers in the New York City public hospital system declined COVID-19 vaccines, Mayor Bill de Blasio said Tuesday.
  • Native American tribes are prioritizing vaccinations for speakers of endangered languages.
  • Holy Cross beat Boston University 68-66 on Tuesday, during the first men’s college basketball game this season in which players wore masks on the court.
  • Jury trials in states across the U.S. – including California, Florida, Arkansas, New Mexico, Tennessee, and Idaho – have shut down as a result of the pandemic. The inability to conduct jury trials has wreaked havoc with the dockets of many courts.
  • Two-time World Cup winner Alex Morgan announced she and her family have tested positive for COVID-19.
  • North Carolina prison officials are considering offering rewards, such as increased guest visitation privileges, to inmates who accept a coronavirus vaccine that will soon become available to them.

1/4/2021

  • The number of inmates and guards known to have been infected with COVID-19 at American correctional institutions has now exceeded 500,000.
  • Moderna said it will produce at least 600 million doses of its coronavirus vaccine in 2021, up by 100 million from its previous forecast.
  • More than fifteen million doses of COVID-19 vaccines have been distributed across the U.S., and 4.5 million people have received their first dose, according to CDC data.
  • BioNTech and Pfizer warned they had no evidence their vaccine would continue to work if the booster shot was given later than tested in trials. They said the “safety and efficacy of the vaccine has not been evaluated on different dosing schedules.”
  • In an attempt to limit the threat of coronavirus among teams, the N.C.A.A. announced an agreement Monday to hold its signature men’s basketball tournament entirely in Indiana in March and early April.
  • The Transportation Security Administration screened more than 1.3 million travelers Sunday, marking yet another pandemic travel record.
  • Sandra Lindsay, director of critical care nursing at Long Island Jewish Medical Center, became the first person in the U.S. to complete a two-dose coronavirus vaccine course on Monday, 21 days after she was given her initial dose of the Pfizer-BioNTech vaccine on Dec. 14.
  • The Ad Council and the COVID Collaborative today announced a new resource designed to address healthcare professionals' questions about COVID-19 vaccination. The videos which feature an introduction from Dr. Anthony Fauci–include experts from a diverse coalition of leading healthcare organizations and medical institutions sharing information around COVID-19 vaccine development and safety with their fellow physicians and nurses.
  • Two more studies show contracting COVID-19 prevents against future infection for 6-8 months. The studies, one from Oxford University and the other by the U.S. National Cancer Institute, are the latest in a series of medical findings that have shown getting COVID-19 provides temporary immunity from reinfection, the Associated Press reported.
  • Sixty percent of nursing home staff in Ohio have refused to take a COVID-19 vaccine.
  • The University of California, San Diego has installed vending machines on campus where students and staff can pick up self-administered COVID-19 test kits. To use the kits, which are free, test takers use the swab outdoors and return the vile within 72 hours, for results in less than two days.
  • Some Chicago Public Schools teachers expected to report to the classroom ahead of preschool students’ anticipated return next week have stayed home over coronavirus concerns. The Chicago Teachers Union opposed the nation’s third-largest district’s plans to bring students back in phases.
  • The Greek Orthodox church has announced it will defy government lockdown orders aimed at curbing the spread of coronavirus and open places of worship to mark Epiphany on Wednesday.
  • Pope Francis on Sunday criticized people who have been traveling abroad for leisure during the pandemic, saying he was disappointed by their lack of consideration for others.
December 2020
November 2020
October 2020
September 2020
August 2020
July 2020
June 2020
May 2020
April 2020